Biotechnology

Featured

Biotech ETFs Prescribe New ETFs

By Todd ShriberOctober 23, 2014

Featured

Biotech ETFs Aren’t Waving the White Flag…Yet

By Tom LydonOctober 15, 2014

Featured

Defensive Health Care ETFs Offer Growth, Too

By Tom LydonSeptember 3, 2014

Featured

ETF Performance Report: An August to Remember

By Tom LydonAugust 31, 2014

Featured

Healthy Earnings Growth Sustains Pricey Biotech ETFs

By Tom LydonAugust 27, 2014

Featured

InterMune Acquisition Could Ignite These Biotech ETFs

By Tom LydonAugust 25, 2014

Featured

Biotech ETFs Capitalize On New Breakthroughs

By Tom LydonAugust 21, 2014

Featured

So Much for That Biotech ETF Bubble

By Todd ShriberAugust 20, 2014

Featured

Active Strategies Continue to Lag Passive Index ETFs

By Tom LydonJuly 29, 2014

Alternative ETFs

Most Searched ETFs: Tech Talk

By Todd ShriberJuly 26, 2014

Featured

Puma Pumps up Biotech ETFs

By Todd ShriberJuly 23, 2014

Featured

Big Week of Earnings for Big Biotech ETF

By Todd ShriberJuly 21, 2014

Contributed

ETF Chart of the Day: Biotech Warnings

By Paul Weisbruch, Street One FinancialJuly 14, 2014

Featured

Biotech ETF Nears a Critical Juncture

By Todd ShriberJune 25, 2014

Featured

Vertex Lifts These Biotech ETFs

By Todd ShriberJune 24, 2014

Featured

Why These Two Biotech ETFs Are Soaring Monday

By Tom LydonJune 9, 2014

Featured

A Stable ETF to Gain Exposure to a Volatile Biotech Sector

By Tom LydonJune 6, 2014

Featured

Technical Analysts See Bullish Signs for Biotech ETFs

By Max ChenJune 5, 2014

Previous 1 … 12 13 14 15 16 … 26 Next